Singapore markets closed

Straits Times Index
3,303.66
+12.96(+0.39%)
S&P 500
5,223.26
+0.58(+0.01%)
Dow
39,529.80
+16.96(+0.04%)
Nasdaq
16,379.15
+38.29(+0.23%)
Bitcoin USD
62,780.73
+1,625.97(+2.66%)
CMC Crypto 200
1,293.94
+33.73(+2.68%)

EW Nov 2024 97.500 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

9.70

0.00

(0.00%)

As of 12:41PM EDT. Market open.

Reuters
Edwards Lifesciences hit with Meril's EU antitrust complaint
U.S. heart valve maker Edwards Lifesciences has been hit with an EU antitrust complaint by Indian rival Meril including for allegedly anti-competitive practices related to patents, a move that could bolster EU regulators' scrutiny of Edwards. Meril has filed a complaint with the European Commission, the company told Reuters. The two companies have for years sparred over heart valve patents in various courts around the world.
Simply Wall St.
Investors in Edwards Lifesciences (NYSE:EW) have seen respectable returns of 50% over the past five years
If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd like to see the share...
Zacks
The Zacks Analyst Blog Highlights Salesforce, BP, The Southern, PayPal and Edwards Lifesciences
Salesforce, BP, The Southern, PayPal and Edwards Lifesciences are included in this Analyst Blog.